Myriad Genetics vs Intellia Therapeutics: revenue, profit, margins and growth compared
Myriad Genetics brought in $824.5M of revenue in fiscal 2025, Intellia Therapeutics $67.7M in fiscal 2025. Revenue changed by -1.6% at Myriad Genetics and +16.9% at Intellia Therapeutics on the year before, so Intellia Therapeutics grew faster. Myriad Genetics kept -44.4% of its revenue as net profit, Intellia Therapeutics -609.9%.
Fiscal years as each company reports them; the two may end in different months.
Questions about Myriad Genetics and Intellia Therapeutics
Which is bigger by revenue, Myriad Genetics or Intellia Therapeutics?
Myriad Genetics is bigger by revenue: $824.5M in fiscal 2025, against $67.7M for Intellia Therapeutics in fiscal 2025.
Which keeps more of its revenue as profit, Myriad Genetics or Intellia Therapeutics?
Myriad Genetics had a net margin of -44.4% in fiscal 2025; Intellia Therapeutics had -609.9% in fiscal 2025.
Which grew revenue faster, Myriad Genetics or Intellia Therapeutics?
In their latest fiscal years revenue changed by -1.6% at Myriad Genetics and +16.9% at Intellia Therapeutics.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.